Guerbet

Guerbet : Adjustment of 2025 full-year financial targets

15 Sep 2025 08:50:00 By Nasdaq GlobeNewswire

Guerbet : H1 2025 revenue

24 Jul 2025 08:45:00 By Nasdaq GlobeNewswire

Guerbet : Changes in the composition of the Guerbet board of directors.

25 May 2025 23:42:52 By Nasdaq GlobeNewswire

Guerbet: Q1 2025 revenue

24 Apr 2025 08:45:00 By Nasdaq GlobeNewswire

GUERBET : 2024 full-year results.

26 Mar 2025 09:45:00 By Nasdaq GlobeNewswire

DUOncoTM Bone : First CE marked IA algorithm for automatic detection of bone lesions on CT scan.

18 Mar 2025 09:45:00 By Nasdaq GlobeNewswire

GUERBET : 2024 revenue.

06 Feb 2025 08:45:00 By Nasdaq GlobeNewswire

GUERBET : Implementation of a Liquidity Contract with NATIXIS ODDO BHF

03 Feb 2025 03:00:00 By Nasdaq GlobeNewswire

Correction: GUERBET : Financial agenda for 2025

31 Oct 2024 10:00:00 By Nasdaq GlobeNewswire

GUERBET : Revenue at September 30, 2024.

24 Oct 2024 08:45:00 By Nasdaq GlobeNewswire

GUERBET : H1 2024 results.

25 Sep 2024 08:45:00 By Nasdaq GlobeNewswire

GUERBET : H1 2024 revenue.

25 Jul 2024 08:45:00 By Nasdaq GlobeNewswire

Guerbet : Hugues Lecat appointed Chairman of the Board of Directors of Guerbet.

24 May 2024 08:44:58 By Nasdaq GlobeNewswire

Guerbet : NUCLIDIUM and Guerbet Form Strategic Partnership to Support the Advancement of targeted Copper-based Radiotheranostics.

22 May 2024 08:45:00 By Nasdaq GlobeNewswire

Guerbet : Q1 2024 revenue.

25 Apr 2024 08:45:00 By Nasdaq GlobeNewswire

Guerbet: Financial agenda for 2024

15 Jan 2024 09:00:00 By Nasdaq GlobeNewswire

GUERBET : Revenue at 30 September 2023.

19 Oct 2023 08:45:00 By Nasdaq GlobeNewswire

Guerbet: CHMP positive opinion

12 Oct 2023 08:57:24 By Nasdaq GlobeNewswire

Guerbet: 2023 half-year results

20 Sep 2023 08:45:00 By Nasdaq GlobeNewswire

Guerbet: First-half 2023 revenue

20 Jul 2023 08:46:36 By Nasdaq GlobeNewswire